M. Mack

5.1k citations
115 papers · 3.8k · 2 hit papers · h-index 34

Impact in

  • Rheumatology top 0.5%
    • Spondyloarthritis Studies and Treatments
    • Rheumatoid Arthritis Research and Therapies
  • Hematology top 2%
    • Autoimmune and Inflammatory Disorders Research

Papers in

    • Integrated Circuits and Semiconductor Failure Analysis 14
    • Semiconductor materials and devices 14
    • Silicon and Solar Cell Technologies 10
    • Spondyloarthritis Studies and Treatments 18
    • Rheumatoid Arthritis Research and Therapies 13

M. Mack

109 papers receiving 3.6k citations

M. Mack's Hit Papers

Golimumab, a new human tumor necrosis factor α antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty‐four–week efficacy and safety results of a randomized, placebo‐controlled study 2009 · 464 citations
4640+6+12Years since publication100200300400

Peers

M. Mack
Comparison fields: 5 of 131
  • Rheumatology 1.5k
  • Hematology 397
  • Infectious Diseases 555
  • Immunology 621
  • Atomic and Molecular Physics, and Optics 773
Replace Kamran Badizadegan with:
Kamran Badizadegan United States
J.P. Martin France
Ichiro Katayama Japan
George W. Nelson United States
Jerrold S. Levine United States
John A. McIntyre United States
Thomas Bardin France
Atsushi Ogata Japan
Peter F. Hahn United States
Takashi Asai Japan
M. Mack relative to Kamran Badizadegan United States Kamran Badizadegan's profile →
Citations per field
00.5×8.8×
Kamran Badizadegan · 1×
Citations per year

Countries citing papers authored by M. Mack

Since Specialization
Citations

This map shows the geographic impact of M. Mack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Mack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Mack more than expected).

Fields of papers citing papers by M. Mack

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Mack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Mack. The network helps show where M. Mack may publish in the future.

Co-authors

The 25 scholars most cited alongside M. Mack, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with M. Mack Line = papers co-authored together M. Mack links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 115 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Golimumab, a new human tumor necrosis factor α antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty‐four–week efficacy and safety results of a randomized, placebo‐controlled study
Hit paper breakdown →
2009464
2
Efficacy and safety of golimumab in patients with ankylosing spondylitis: Results of a randomized, double‐blind, placebo‐controlled, phase III trial
Hit paper breakdown →
2008448
3
Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines--report of the National Multicenter Trial. United States Rotavirus Vaccine Efficacy Group.
1996244
4 2012169
5 1969154
6 1997126
7 2015106
8 200584
9 199683
10 201182
11 201282
12 198978
13 201273
14 197271
15 201369
16 199761
17 196854
18 201050
19 198750
20 201249

About M. Mack

M. Mack is a scholar working on Electrical and Electronic Engineering, Rheumatology, Atomic and Molecular Physics, and Optics, Computational Mechanics and Infectious Diseases, having authored 115 papers that have together received 3.8k indexed citations. Recurring topics across this work include Spondyloarthritis Studies and Treatments (18 papers), Integrated Circuits and Semiconductor Failure Analysis (14 papers), Semiconductor materials and devices (14 papers), Rheumatoid Arthritis Research and Therapies (13 papers), Ion-surface interactions and analysis (11 papers), Laser-Matter Interactions and Applications (11 papers), Silicon and Solar Cell Technologies (10 papers) and Advanced Fiber Laser Technologies (9 papers). The work is most often cited by research in Rheumatology (1.5k citations), Hematology (397 citations), Infectious Diseases (555 citations), Immunology (621 citations) and Atomic and Molecular Physics, and Optics (773 citations). M. Mack has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Anna Beutler, Sudha Visvanathan, Désirée van der Heijde, Benjamin Hsu, Jürgen Braun, Robert D. Inman, A. Niehaus, Philip J. Mease, Gerald G. Krueger and Edward T. Zito. Their work appears in journals such as Nuclear Instruments and Methods in Physics Research Section B Beam Interactions with Materials and Atoms, Annals of the Rheumatic Diseases, Applied Physics Letters, The Journal of Rheumatology and Arthritis Care & Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact